Paper Details

  1. Home
  2. Paper Details

Extrapyramidal side effects and tolerability of risperidone: a review.

Author: OwensD G

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Risperidone was better tolerated than haloperidol in two large clinical trials of schizophrenic patients.
Paper Details　
Original Abstract of the Article :
The effectiveness of conventional neuroleptics in schizophrenia is often limited by extrapyramidal side effects (EPS), which are known to contribute to poor compliance and relapse. However, there is now evidence that drugs that block 5-HT2 receptors as well as D2 receptors have better EPS profiles. ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/7520906

データ提供：米国国立医学図書館（NLM）

Risperidone: A Tolerable Antipsychotic with a Favorable Extrapyramidal Side Effect Profile

The treatment of [schizophrenia] is often challenging due to the [extrapyramidal side effects (EPS)] associated with traditional antipsychotic medications. These side effects can contribute to [poor compliance] and [relapse]. This review explores the [tolerability] and [EPS profile] of [risperidone], a newer atypical antipsychotic medication. The review summarizes the findings of two large clinical trials comparing risperidone to placebo and haloperidol, a conventional antipsychotic.

Risperidone's Favorable Side Effect Profile

The review concludes that risperidone, at antipsychotic doses, is generally well tolerated and has a significantly better EPS profile than haloperidol. This makes risperidone a more attractive option for patients with schizophrenia, as it can help to improve medication adherence and reduce the risk of relapse. The review also highlights the importance of considering the individual needs and preferences of patients when choosing an antipsychotic medication.

Improving Treatment Options for Schizophrenia

This review offers a valuable insight into the potential benefits of [risperidone] for patients with [schizophrenia]. It's like discovering a new and more comfortable way to travel across the desert, offering a smoother and more enjoyable journey. This research emphasizes the importance of seeking new and improved treatment options for mental health conditions, ultimately aiming to improve the quality of life for those affected.

Dr.Camel's Conclusion

This review highlights the progress being made in the development of [antipsychotic medications]. It's like a camel caravan venturing into new territory, seeking more efficient and reliable ways to navigate the challenges of the desert. By exploring new treatment options and understanding the individual needs of patients, we can continue to improve the lives of those with [schizophrenia] and other mental health conditions.

Date :
  1. Date Completed 1994-09-29
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

7520906

DOI: Digital Object Identifier

7520906

Related Literature

Article Analysis
・Side Effects of risperidone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.